News
National brain tumour research funding needs to increase to £35 million a year
Young patient’s family to lead Walk of Hope

The
family of a young girl living with the life-changing effects of a brain tumour
will lead supporters at our flagship Walk of
Hope in Newcastle.
Eleanore
Guthrie was just four years old
when she was diagnosed with a craniopharyngioma in 2021. She has had seven operations and undergone proton
beam therapy, and has been left with adrenal insufficiency, diabetes insipidus
and an underactive thyroid which means she has no growth hormone function.
On
Saturday 30th September, Eleanore’s family will lead walkers on a
5km route at the Town Moor
in Newcastle. It’s one of three
flagship Walk of Hope events being organised by Brain Tumour Research, each
with a festival atmosphere, including entertainment as well as food and drink
stalls. Our flagship events are also taking place in Ellesmere
in Shropshire and Luton in Bedfordshire, with more walks being
held across the UK.
Eleanore’s
mum Karen said: “The lack of funding and research into brain tumours is
shocking and more needs to be done. The oncologist told me that, without
research, Eleanore’s type of tumour will never get a full treatment plan, so we
would never know why it happened and how to best treat it.
She
added: “This is the hand we’ve been dealt so we want to get on with it and
do what we can to help tackle this devastating disease.”
Join
our Walk of Hope and you’ll be united with a community of people with one
common goal – to find a cure for brain tumours. Register before Monday 31st
July to secure your early bird discount of 50% on your registration fee. Find
your nearest walk by clicking here.
If
you can’t make it to any of our walks, you can still get involved by setting up
your own event where you are and whenever you can. Find out more about planning
your own Walk of Hope here.
Related reading:
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.